1
Total investments
0
Early stage
0
Mid stage
0
Late stage
3y
Years active
Portfolio
0 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
No investments found
Experience · 4 entries
All (4)
Investments (1)
Founder (2)
2023
Angel Investor
2023
HealthTech Capital is a group of private investors dedicated to funding and mentoring new “HealthTech” start ups at the intersection of healthcare and the computer/consumer electronic world.
Our goal is to invest and mentor capital efficient companies that use new scalable business model to improve the efficiency of healthcare delivery from the hospital to the home.
HealthTech is now an exploding healthcare market that leverages information technologies to decrease healthcare cost. Historically, venture funding has focused on “Efficacy” (therapeutics drugs and medical devices) and paid little attention to improving “Efficiencies” of healthcare delivery. Today, new paradigm shifting companies like Google, Microsoft, Intel, Apple, Amazon and others are turning their attention to HealthTech.
HealthTech supports patient-centric healthcare and is distinct from Healthcare IT, enterprise backbone legacy information systems that are well served by existing major players. Our goal is to invest in capital efficient companies that use new business models to improve the efficiency of healthcare delivery.
Associate Director, Global Strategic Marketing
2023
FRAUD ALERT: Please take note that it has come to our attention that individuals purporting to work for Repligen are reaching out to prospective job applicants using fraudulent email addresses. All legitimate communications from Repligen will be sent from an individual with an email address ending in @repligen.com. If you have any concerns that a communication may be fraudulent and you would like to confirm whether it is, you may email legal@repligen.com and someone will respond.
Repligen is a bioprocessing-focused life sciences company bringing over 40 years of expertise and innovation to our customers. We are inspiring advances in bioprocessing through the development and commercialization of high-value products and flexible solutions that address critical steps in the production of biologic drugs, principally monoclonal antibodies.
Repligen headquarters is in Waltham, Massachusetts and our manufacturing facilities are located around the world. We market our products globally through a direct commercial organization in the U.S., Europe and Asia, as well as through strategic partners in select markets.
2016
2006
B
Bacio Cafe
Founder/Owner
2006
